Clinical Trial

Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a multi-center, open-label extension (OLE) study in patients with plaque psoriasis who have completed their participation in a previous plaque psoriasis study of ESK-001.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-12-01 -> 2027-12-01 2026-07-29
minor Completion pushed: 2026-12-30 -> 2027-12-31 2026-07-29
Trial Details
NCT Number NCT05739435
Lead Sponsor Alumis Inc
Conditions Plaque Psoriasis
Enrollment 165 participants
Start Date 2023-01-17
Primary Completion 2027-12-01 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-28